rfhg_104282.1

Basic information about the TSS

---

TSS ID: rfhg_104282.1 TSS ID(Version3): hg_92205.1 hg_92206.1 Species: human Chr: chr8		Start: 22141850 End: 22141956 Strand: -
Source datasets	FANTOM5|PRJNA615891|PRJNA4843412|DRA013844|PRJNA548673 |PRJDB5282|PRJNA401781
Protocol	CAGE|TIF-seq2|NETCAGE|C1CAGE|SLIC_CAGE|ReCappable-seq |RAMPAGE|oligo_capping
TSS cluster detected*	11

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D4070337,EH38E2616127)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000334530.9:0 ENST00000306306.8:0 ENST00000518664.5:0 ENST00000521744.1:0 BC050622:0 BC013048:0 AK172846:0 AK025899:0 GeneID: 80346 HGNC/MGI_ID: HGNC:26176 UniProt_ID: E5RIB5 Q9H6H4 Nearer transcript ids and distances: ENST00000519875.1:81 ENST00000519074.5:82 AK302352:82 AF218014:121 AK025930:266 ENST00000523293.2:310 AY562242:368 JF432791:368 KJ894819:368 CR457353:368 view more...

Gene_name: receptor accessory protein 4 Gene_symbol: REEP4 Gene_synonyms: FLJ22246 FLJ22277 PP432 Yip2c Gene_source: HGNC:26176

TATA-Box annotation

---

Distance to TSS:	4
Nearest PromoterID:	NM_001316964
Entrez ID:	80346
Nearest Unigene:	Hs.289063
Nearest Refseq:	NM_025232
Nearest Ensembl:	ENSG00000168476
Gene Name:	receptor accessory protein 4
Gene Alias:	C8orf20|PP432|Yip2c
Gene Type:	protein-coding
CpG%:	0.075472
GC%:	0.654206
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@REEP4 p2@REEP4
Sample		p1@REEP4	p2@REEP4
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	76.56	8.57
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	82.75	11.33
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	79.86	7.52
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	84.62	7.28
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	85.94	6.97
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	84.70	6.01
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	112.65	10.46
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	111.91	11.87
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	112.63	14.32
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	152.44	12.75
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	124.10	12.53
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	135.38	11.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	23.70	3.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	19.85	3.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	21.30	4.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	18.36	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	17.04	3.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	21.51	4.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	18.66	3.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	16.70	4.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	20.72	3.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	21.58	3.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	18.23	4.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	20.14	3.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	20.38	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	23.11	3.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	20.88	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	16.97	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	20.03	3.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	16.29	2.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	19.47	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	19.73	2.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	18.99	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	11.55	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	14.59	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	18.01	3.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	17.37	2.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	10.68	2.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	13.78	2.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	13.20	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	13.17	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	14.05	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	13.50	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	16.26	2.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	14.05	3.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	14.89	4.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	17.99	4.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	23.25	2.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	23.70	4.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	20.62	3.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	23.16	3.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	29.13	6.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	18.45	3.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	20.55	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	5.87	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	19.29	2.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	26.58	3.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	27.62	3.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	24.83	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	19.74	4.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	18.51	5.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	15.92	4.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	26.50	3.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	29.89	5.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	29.46	5.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	23.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	23.89	6.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	25.79	4.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	24.39	4.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	26.16	6.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	25.06	5.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	26.91	6.11
Adipocyte - breast, donor1	11376-118A8	18.85	1.27
Adipocyte - breast, donor2	11327-117E4	15.40	1.76
Adipocyte - omental, donor1	11473-119C6	19.08	1.27
Adipocyte - omental, donor2	11474-119C7	17.19	1.49
Adipocyte - omental, donor3	11475-119C8	6.36	1.00
Adipocyte - perirenal, donor1	11476-119C9	10.21	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	8.80	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	15.81	1.81
Adipocyte - subcutaneous, donor3	11408-118E4	11.99	2.09
Adipocyte differentiation, day04, donor1	13019-139D4	17.80	0.98
Adipocyte differentiation, day04, donor2	13022-139D7	15.96	1.80
Adipocyte differentiation, day04, donor3	13025-139E1	17.01	3.62
Adipocyte differentiation, day04, donor4	13028-139E4	22.92	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	14.80	1.13
Adipocyte differentiation, day08, donor2	13023-139D8	17.75	1.61
Adipocyte differentiation, day08, donor3	13026-139E2	9.06	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	10.57	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	12.89	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	13.06	1.26
Adipocyte differentiation, day12, donor3	13027-139E3	11.13	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	8.83	0.91
Alveolar Epithelial Cells, donor1	11510-119G7	46.63	7.96
Alveolar Epithelial Cells, donor2	11590-120G6	60.60	11.12
Alveolar Epithelial Cells, donor3	11671-122G6	14.38	5.99
Amniotic Epithelial Cells, donor1	11533-120A3	29.14	7.74
Amniotic Epithelial Cells, donor2	11613-122A2	18.41	5.02
Amniotic Epithelial Cells, donor3	11694-123A2	29.17	6.99
Anulus Pulposus Cell, donor1	11248-116E6	10.07	1.49
Anulus Pulposus Cell, donor2	11463-119B5	12.49	3.67
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	11.23	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	14.76	3.47
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	23.54	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	14.35	2.69
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	10.12	3.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	11.22	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	12.02	1.95
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	15.05	1.94
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	8.31	2.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	12.05	3.39
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	13.79	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	18.81	2.51
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	11.70	3.46
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	9.55	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	15.23	2.26
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	15.00	2.14
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	10.39	3.21
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	14.70	1.34
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	14.63	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	14.60	1.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	13.21	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	14.58	2.74
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	17.48	2.43
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	14.80	2.66
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	10.90	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	13.68	2.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	14.96	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	15.23	3.36
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	9.85	2.82
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	13.51	1.61
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	12.13	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	10.53	2.92
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	11.14	3.01
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	23.76	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	18.31	2.54
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	12.99	2.80
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	13.34	3.18
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	18.56	3.88
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	13.97	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	14.79	2.32
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	13.23	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	14.75	2.20
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	11.58	4.63
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	4.23	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	13.29	2.14
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	14.44	1.80
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	10.93	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	14.25	3.91
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	7.65	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	16.53	4.58
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	15.69	2.06
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	15.91	2.14
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	17.21	3.82
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	16.41	3.55
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	24.41	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	13.29	3.32
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	14.56	2.91
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	13.81	3.27
Astrocyte - cerebellum, donor1	11500-119F6	47.53	10.56
Astrocyte - cerebellum, donor2	11580-120F5	41.59	9.24
Astrocyte - cerebellum, donor3	11661-122F5	22.65	2.52
Astrocyte - cerebral cortex, donor1	11235-116D2	26.14	3.14
Astrocyte - cerebral cortex, donor2	11316-117D2	46.59	5.50
Astrocyte - cerebral cortex, donor3	11392-118C6	48.03	6.12
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	41.52	8.26
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	42.09	5.76
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	48.36	7.74
Basophils, donor1	12241-129G9	44.72	2.09
Basophils, donor2	12242-129H1	60.25	3.25
Basophils, donor3	12243-129H2	53.07	3.38
Bronchial Epithelial Cell, donor1	11511-119G8	92.92	7.11
Bronchial Epithelial Cell, donor2	11591-120G7	122.53	14.63
Bronchial Epithelial Cell, donor3	11672-122G7	64.56	28.69
Bronchial Epithelial Cell, donor4	11453-119A4	72.18	6.28
Bronchial Epithelial Cell, donor5	11457-119A8	60.72	6.03
Bronchial Epithelial Cell, donor6	11461-119B3	70.93	5.76
Bronchial Epithelial Cell, donor7	11769-123I5	59.38	5.22
Burkitt's lymphoma cell line:DAUDI	10422-106C8	43.90	4.53
Burkitt's lymphoma cell line:RAJI	10476-106I8	34.70	4.19
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	40.29	6.72
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	10.34
CD14+ Monocytes, donor1	11224-116B9	52.97	2.25
CD14+ Monocytes, donor2	11305-117B9	40.28	2.78
CD14+ Monocytes, donor3	11381-118B4	47.64	2.41
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	91.14	9.06
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	95.15	7.20
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	101.91	6.25
CD14+ monocytes - mock treated, donor1	11863-125A9	89.91	2.17
CD14+ monocytes - mock treated, donor2	11873-125C1	37.11	1.81
CD14+ monocytes - mock treated, donor3	11883-125D2	64.67	2.84
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	28.46	1.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	22.08	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	24.30	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	24.87	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	32.23	1.25
CD14+ monocytes - treated with BCG, donor3	11880-125C8	29.82	1.74
CD14+ monocytes - treated with Candida, donor1	11868-125B5	31.37	1.17
CD14+ monocytes - treated with Candida, donor2	11878-125C6	25.35	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	22.19	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	47.00	1.19
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	26.94	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	28.11	1.25
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	37.52	1.83
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	30.76	0.68
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	25.75	1.75
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	39.00	2.96
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	37.33	1.22
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	42.92	2.52
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	13.59	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	17.26	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	18.87	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	26.85	1.22
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	31.22	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	35.78	2.16
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	18.43	1.64
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	15.30	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	17.63	1.16
CD14+CD16+ Monocytes, donor1	11789-124B7	57.11	3.71
CD14+CD16+ Monocytes, donor2	11801-124D1	63.75	2.08
CD14+CD16+ Monocytes, donor3	11912-125G4	53.72	1.95
CD14+CD16- Monocytes, donor1	11788-124B6	97.33	5.45
CD14+CD16- Monocytes, donor2	11799-124C8	78.59	4.19
CD14+CD16- Monocytes, donor3	11910-125G2	75.14	5.57
CD14-CD16+ Monocytes, donor1	11790-124B8	46.70	3.06
CD14-CD16+ Monocytes, donor2	11800-124C9	47.21	2.63
CD14-CD16+ Monocytes, donor3	11911-125G3	50.53	2.11
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	14.23	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	14.24	8.14
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	19.68	6.21
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	21.85	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	14.47	2.14
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	10.53	4.21
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	25.88	4.71
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	11.86	3.95
CD19+ B Cells, donor1	11544-120B5	14.79	0.82
CD19+ B Cells, donor2	11624-122B4	15.96	2.90
CD19+ B Cells, donor3	11705-123B4	10.10	4.04
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	118.79	6.87
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	133.43	6.79
CD34+ Progenitors, donor1	11545-120B6	23.09	3.01
CD34+ Progenitors, donor2	11625-122B5	21.35	5.06
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	40.58	10.52
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	48.03	9.92
CD4+ T Cells, donor1	11225-116C1	14.64	2.14
CD4+ T Cells, donor2	11306-117C1	36.13	1.22
CD4+ T Cells, donor3	11382-118B5	28.36	3.96
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	23.74	3.57
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	33.24	5.17
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	35.36	3.74
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	25.13	3.79
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	16.86	5.62
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	16.48	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	31.65	4.05
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	49.48	3.90
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	62.87	4.35
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	24.21	4.03
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	15.02	5.24
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	32.12	3.96
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	25.30	2.95
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	32.41	5.82
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	34.75	6.35
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	14.96	5.17
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	16.61	3.75
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	8.97	7.17
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	50.62	6.12
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	48.52	5.63
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	56.32	5.04
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	26.29	6.57
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	21.66	2.60
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	24.41	6.54
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	26.72	6.43
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	20.31	8.31
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	32.10	4.19
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	31.57	6.37
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	30.67	5.15
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	18.48	4.62
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	39.39	7.16
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	36.01	8.31
CD8+ T Cells, donor1	11226-116C2	33.39	4.91
CD8+ T Cells, donor2	11307-117C2	61.20	1.88
CD8+ T Cells, donor3	11383-118B6	30.30	3.79
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	52.53	11.93
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	45.05	8.87
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	48.97	9.85
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	38.13	6.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	42.96	7.68
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	46.61	11.37
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	63.45	7.82
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	61.33	8.42
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	54.88	7.74
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	69.73	9.36
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	80.47	8.42
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	65.01	10.66
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	39.40	6.57
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	44.63	7.74
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	54.45	5.97
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	52.22	7.20
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	52.65	8.06
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	43.60	5.66
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	53.24	7.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	68.89	10.76
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	53.86	9.30
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	63.49	10.71
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	69.36	9.06
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	70.35	10.59
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	50.59	7.23
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	42.67	6.99
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	41.07	8.01
Cardiac Myocyte, donor1	11525-119I4	3.66	1.83
Cardiac Myocyte, donor2	11605-120I3	14.33	1.48
Cardiac Myocyte, donor3	11686-122I3	28.94	3.37
Chondrocyte - de diff, donor1	11261-116G1	78.69	3.81
Chondrocyte - de diff, donor2	11338-117F6	9.60	1.07
Chondrocyte - de diff, donor3	11410-118E6	13.08	1.82
Chondrocyte - re diff, donor2	11339-117F7	14.32	0.90
Chondrocyte - re diff, donor3	11411-118E7	14.15	1.62
Ciliary Epithelial Cells, donor1	11242-116D9	26.28	3.44
Ciliary Epithelial Cells, donor2	11323-117D9	20.95	3.21
Ciliary Epithelial Cells, donor3	11399-118D4	19.65	4.60
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	26.78	4.40
Corneal Epithelial Cells, donor1	11526-119I5	87.39	13.17
Corneal Epithelial Cells, donor2	11606-120I4	110.35	5.69
Corneal Epithelial Cells, donor3	11687-122I4	100.97	10.23
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	47.22	4.46
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	46.68	4.73
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	41.41	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	36.07	2.38
Dendritic Cells - plasmacytoid, donor1	11228-116C4	19.13	4.78
Dendritic Cells - plasmacytoid, donor2	11309-117C4	11.75	3.26
Dendritic Cells - plasmacytoid, donor3	11385-118B8	21.78	3.87
Endothelial Cells - Aortic, donor0	11207-116A1	29.85	3.50
Endothelial Cells - Aortic, donor1	11263-116G3	21.12	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	41.57	4.52
Endothelial Cells - Aortic, donor3	11412-118E8	14.15	1.57
Endothelial Cells - Artery, donor1	11264-116G4	27.05	2.62
Endothelial Cells - Artery, donor2	11341-117F9	44.70	5.18
Endothelial Cells - Artery, donor3	11413-118E9	31.56	4.21
Endothelial Cells - Lymphatic, donor1	11236-116D3	17.07	1.33
Endothelial Cells - Lymphatic, donor2	11317-117D3	16.73	3.35
Endothelial Cells - Lymphatic, donor3	11393-118C7	13.53	3.66
Endothelial Cells - Microvascular, donor1	11265-116G5	30.31	5.05
Endothelial Cells - Microvascular, donor2	11342-117G1	16.66	3.12
Endothelial Cells - Microvascular, donor3	11414-118F1	25.10	3.69
Endothelial Cells - Thoracic, donor1	11266-116G6	42.01	3.60
Endothelial Cells - Thoracic, donor2	11343-117G2	33.02	2.62
Endothelial Cells - Umbilical vein, donor1	11243-116E1	47.96	3.35
Endothelial Cells - Umbilical vein, donor2	11324-117E1	54.10	4.56
Endothelial Cells - Umbilical vein, donor3	11400-118D5	66.44	5.37
Endothelial Cells - Vein, donor1	11267-116G7	46.64	6.83
Endothelial Cells - Vein, donor2	11344-117G3	44.01	7.68
Endothelial Cells - Vein, donor3	11416-118F3	30.77	4.24
Eosinophils, donor1	12244-129H3	45.74	0.00
Eosinophils, donor2	12245-129H4	39.61	0.00
Eosinophils, donor3	12246-129H5	32.10	7.13
Esophageal Epithelial Cells, donor1	11507-119G4	71.10	8.06
Esophageal Epithelial Cells, donor2	11587-120G3	128.97	4.16
Esophageal Epithelial Cells, donor3	11668-122G3	97.61	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	20.94	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	17.85	2.30
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	21.78	0.65
Fibroblast - Aortic Adventitial, donor1	11245-116E3	25.23	3.27
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	23.34	4.78
Fibroblast - Aortic Adventitial, donor2	11326-117E3	15.29	1.58
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	54.81	10.54
Fibroblast - Aortic Adventitial, donor3	11401-118D6	40.53	4.65
Fibroblast - Cardiac, donor1	11268-116G8	25.86	2.27
Fibroblast - Cardiac, donor2	11345-117G4	38.66	6.06
Fibroblast - Cardiac, donor3	11417-118F4	28.55	5.05
Fibroblast - Cardiac, donor4	11452-119A3	16.97	1.82
Fibroblast - Cardiac, donor5	11456-119A7	22.84	2.54
Fibroblast - Cardiac, donor6	11460-119B2	35.47	2.58
Fibroblast - Choroid Plexus, donor1	11492-119E7	22.91	4.56
Fibroblast - Choroid Plexus, donor2	11572-120E6	12.51	5.18
Fibroblast - Choroid Plexus, donor3	11653-122E6	46.87	8.79
Fibroblast - Conjunctival, donor1	11531-120A1	57.43	10.84
Fibroblast - Conjunctival, donor3	11692-122I9	12.21	3.05
Fibroblast - Dermal, donor1	11269-116G9	18.31	2.82
Fibroblast - Dermal, donor2	11346-117G5	25.47	5.19
Fibroblast - Dermal, donor3	11418-118F5	18.13	1.81
Fibroblast - Dermal, donor4	11450-119A1	41.49	9.16
Fibroblast - Dermal, donor5	11454-119A5	34.89	5.93
Fibroblast - Dermal, donor6	11458-119A9	41.58	6.33
Fibroblast - Gingival, donor1	11237-116D4	13.12	2.92
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	28.56	2.88
Fibroblast - Gingival, donor2	11318-117D4	34.00	6.98
Fibroblast - Gingival, donor3	11394-118C8	16.92	2.32
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	8.31	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	15.51	1.59
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	57.84	3.74
Fibroblast - Gingival, donor6 (control)	11922-125H5	39.62	3.11
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	75.87	10.94
Fibroblast - Gingival, donor7 (control)	11924-125H7	42.85	3.07
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	40.77	4.50
Fibroblast - Gingival, donor8 (control)	11926-125H9	72.40	5.59
Fibroblast - Gingival, donor9 (control)	11927-125I1	22.45	3.37
Fibroblast - Lung, donor1	11270-116H1	16.31	4.08
Fibroblast - Lung, donor2	11347-117G6	23.87	4.48
Fibroblast - Lung, donor3	11419-118F6	40.52	5.70
Fibroblast - Lymphatic, donor1	11506-119G3	51.65	9.16
Fibroblast - Lymphatic, donor2	11586-120G2	23.78	4.20
Fibroblast - Lymphatic, donor3	11667-122G2	27.43	2.80
Fibroblast - Mammary, donor1	11540-120B1	57.65	8.53
Fibroblast - Mammary, donor2	11620-122A9	15.98	3.99
Fibroblast - Mammary, donor3	11701-123A9	23.83	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	29.87	4.27
Fibroblast - Periodontal Ligament, donor2	11319-117D5	52.79	7.58
Fibroblast - Periodontal Ligament, donor3	11395-118C9	25.09	2.14
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	32.44	2.67
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	23.22	3.24
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	22.96	1.86
Fibroblast - Pulmonary Artery, donor1	11250-116E8	51.40	5.42
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	42.87	6.71
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	42.77	5.35
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	18.98	3.16
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	59.53	10.52
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	14.39	1.60
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	17.15	1.38
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	62.58	8.42
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	17.92	1.62
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	24.80	4.81
Fibroblast - skin normal, donor1	11553-120C5	16.41	2.13
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	82.21	11.63
Fibroblast - skin normal, donor2	11561-120D4	32.45	4.02
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	35.06	5.74
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	15.82	2.07
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	18.12	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	57.48	9.20
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	33.55	3.30
Fibroblast - skin walker warburg, donor1	11554-120C6	33.23	3.88
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	12.55	2.67
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	130.73	3.49
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	92.92	5.20
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	65.06	5.73
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	76.91	4.60
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	62.01	9.95
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	38.92	5.74
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	102.69	9.13
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	87.14	22.89
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	71.47	15.75
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	88.17	15.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	87.49	22.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	83.49	17.94
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	76.95	6.63
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	52.15	7.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	43.84	8.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	57.75	5.10
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	46.58	7.68
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	48.31	6.78
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	44.73	5.90
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	41.98	7.76
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	38.62	5.85
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	49.18	6.56
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	44.91	6.50
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	41.17	5.56
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	41.33	6.26
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	43.96	5.44
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	37.83	6.79
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	46.20	6.30
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	44.22	10.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	43.89	10.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	40.50	8.30
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	46.34	5.99
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	39.41	7.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	39.20	9.28
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	35.51	8.76
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	48.86	10.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	43.87	7.27
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	39.48	9.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	48.63	5.67
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	42.66	10.26
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	38.85	8.34
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	45.87	8.54
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	45.31	7.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	31.68	6.48
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	44.79	7.68
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	40.12	5.33
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	36.20	6.11
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	45.73	5.62
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	54.62	7.50
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	47.28	6.22
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	43.91	5.69
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	36.87	5.53
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	29.83	6.58
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	48.60	8.93
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	36.28	5.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	31.27	5.25
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	43.46	8.13
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	61.11	8.36
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	56.08	5.24
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	61.78	7.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	86.06	6.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	65.84	6.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	51.19	8.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	81.67	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	57.63	4.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	64.18	8.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	53.90	6.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	52.08	2.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	52.30	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	79.97	10.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	56.21	5.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	53.60	4.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	66.27	10.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	53.12	6.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	57.06	4.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	50.12	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	50.40	6.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	45.29	3.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	30.49	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	46.81	6.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	44.88	5.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	36.52	5.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	51.50	4.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	61.53	4.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	36.60	10.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	51.35	3.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	44.73	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	37.75	7.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	31.99	9.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	47.31	5.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	38.69	5.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	36.01	7.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	40.13	4.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	35.59	7.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	39.06	6.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	31.36	5.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	37.01	3.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	34.45	2.91
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	14.84	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	11.23	2.49
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	35.98	6.75
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	28.86	1.90
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	26.32	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	36.21	3.48
Hep-2 cells mock treated, biol_rep2	11899-125E9	37.81	3.88
Hep-2 cells mock treated, biol_rep3	11900-125F1	36.17	1.59
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	40.12	4.15
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	38.68	4.08
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	36.81	2.80
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	40.72	2.49
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	33.80	2.23
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	30.76	1.60
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	37.49	7.28
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	43.28	6.92
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	44.94	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	28.92	3.88
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	29.79	5.09
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	52.10	6.64
Hepatocyte, donor1	11523-119I2	8.47	0.00
Hepatocyte, donor2	11603-120I1	15.08	1.08
Hepatocyte, donor3	11684-122I1	12.88	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	48.95	9.79
Intestinal epithelial cells (polarized), donor1	11246-116E4	51.91	4.02
Iris Pigment Epithelial Cells, donor1	11530-119I9	21.82	3.57
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	133.72	22.29
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	93.45	20.03
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	243.75	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	112.13	18.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	105.11	15.02
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	59.34	59.34
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	158.90	33.32
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	105.13	13.71
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	133.19	22.74
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	95.04	16.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	116.18	18.15
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	138.96	26.47
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	79.82	16.63
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	99.53	15.71
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	110.86	15.12
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	119.09	9.28
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	117.08	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	126.62	23.90
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	127.18	25.76
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	215.07	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	137.71	19.56
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	113.35	22.25
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	158.10	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	126.18	17.68
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	82.17	17.54
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	105.57	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	96.30	13.22
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	91.61	14.51
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	147.42	29.48
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	142.05	19.37
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	107.99	22.87
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	115.01	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	149.22	26.14
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	145.81	25.52
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	94.83	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	126.39	19.28
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	112.82	36.50
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	166.79	20.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	90.13	11.11
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	133.46	24.58
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	125.73	15.72
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	130.73	17.38
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	152.70	35.41
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	110.23	16.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	114.22	21.80
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	134.99	13.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	153.32	20.91
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	119.48	11.73
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	94.21	6.93
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	151.03	14.25
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	120.58	15.65
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	133.11	18.15
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	149.01	24.83
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	113.14	15.86
Keratinocyte - epidermal, donor1	11272-116H3	60.95	5.88
Keratinocyte - epidermal, donor2	11349-117G8	66.76	5.86
Keratinocyte - epidermal, donor3	11421-118F8	55.28	5.40
Keratinocyte - oral, donor1	11251-116E9	68.79	7.95
Keratocytes, donor1	11527-119I6	33.01	6.19
Keratocytes, donor2	11607-120I5	43.36	7.03
Keratocytes, donor3	11688-122I5	15.61	1.78
Krukenberg tumor cell line:HSKTC	10687-109F3	39.56	4.40
Lens Epithelial Cells, donor1	11529-119I8	25.89	3.24
Lens Epithelial Cells, donor2	11609-120I7	21.68	4.61
Lens Epithelial Cells, donor3	11690-122I7	22.70	4.74
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	23.48	2.85
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	30.98	2.79
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	19.83	1.42
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	20.43	3.76
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	19.54	2.84
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	20.81	2.70
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	20.93	1.64
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	24.02	1.77
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	17.88	2.96
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	18.99	4.75
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	19.58	2.52
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	19.44	2.59
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	17.77	4.88
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	19.56	1.67
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	20.05	3.71
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	16.94	3.39
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	19.64	2.81
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	24.34	2.38
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	19.42	1.97
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	23.14	2.34
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	25.89	2.74
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	21.34	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	22.89	2.96
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	21.19	2.57
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	16.07	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	17.80	2.09
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	19.25	2.71
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	20.64	3.44
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	16.56	2.26
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	24.60	2.44
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	23.26	1.94
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	20.18	4.30
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	22.92	2.48
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	18.88	2.96
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	17.30	1.73
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	19.25	2.20
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	14.47	2.57
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	23.74	2.74
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	20.99	2.52
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	22.04	1.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	21.81	1.45
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	29.88	3.42
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	21.84	2.51
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	26.13	3.27
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	26.84	4.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	25.25	2.60
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	26.38	2.05
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	29.24	4.18
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	97.44	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	72.88	6.14
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	69.77	3.71
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	91.82	6.77
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	73.15	2.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	81.26	4.67
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	70.08	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	90.40	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	73.97	2.94
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	61.36	2.33
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	54.47	4.50
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	79.94	4.74
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	78.57	3.59
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	69.87	3.18
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	52.64	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	80.99	5.60
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	65.63	5.60
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	67.45	4.72
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	87.74	3.07
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	82.36	6.52
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	61.64	1.87
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	60.82	3.92
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	81.40	4.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	62.71	3.19
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	62.18	2.99
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	66.94	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	83.42	5.66
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	77.81	2.21
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	75.98	6.91
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	82.51	8.06
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	73.03	8.49
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	66.46	4.92
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	85.86	3.16
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	68.94	6.46
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	86.64	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	73.95	2.60
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	61.60	2.58
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	76.21	2.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	82.96	3.66
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	77.22	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	76.08	4.98
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	73.56	3.09
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	66.02	3.22
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	68.01	5.39
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	74.08	2.96
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	70.94	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	75.10	4.23
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	78.83	3.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	74.87	2.91
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	88.92	3.83
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	72.02	2.96
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	98.80	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	82.97	2.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	82.91	2.70
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	86.06	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	83.28	4.01
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	85.24	3.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	63.99	3.30
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	83.03	2.08
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	91.45	2.63
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	58.15	3.35
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	74.20	3.53
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	72.51	5.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	66.84	4.05
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	63.44	3.36
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	74.74	3.98
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	60.76	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	47.73	4.15
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	67.26	3.80
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	68.68	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	81.02	4.23
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	69.72	3.49
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	72.50	2.13
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	71.26	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	79.19	3.09
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	74.27	5.66
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	80.02	6.24
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	91.11	3.33
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	90.83	7.05
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	78.92	5.43
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	101.76	3.25
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	70.92	2.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	86.61	2.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	91.73	4.85
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	83.52	8.26
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	73.80	5.33
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	98.59	4.56
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	69.02	6.90
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	68.94	4.92
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	79.29	4.90
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	58.49	3.38
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	53.05	2.65
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	78.99	18.71
Macrophage - monocyte derived, donor1	11232-116C8	62.22	5.70
Macrophage - monocyte derived, donor2	11313-117C8	17.25	2.94
Macrophage - monocyte derived, donor3	11389-118C3	43.65	4.59
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	44.61	3.19
Mallassez-derived cells, donor2	11929-125I3	40.25	4.12
Mallassez-derived cells, donor3	11930-125I4	50.31	5.14
Mammary Epithelial Cell, donor1	11273-116H4	102.53	10.06
Mammary Epithelial Cell, donor2	11350-117G9	88.89	10.13
Mammary Epithelial Cell, donor3	11422-118F9	67.59	5.49
Mast cell - stimulated, donor1	11487-119E2	9.49	0.68
Mast cell, donor1	11563-120D6	41.31	4.97
Mast cell, donor2	11565-120D8	35.66	9.81
Mast cell, donor3	11566-120D9	32.42	9.00
Mast cell, donor4	11567-120E1	36.70	8.69
Mast cell, expanded and stimulated, donor5	11940-126A5	46.46	5.99
Mast cell, expanded and stimulated, donor8	11942-126A7	98.06	7.59
Mast cell, expanded, donor5	11939-126A4	57.36	6.77
Mast cell, expanded, donor8	11941-126A6	168.20	11.88
Melanocyte - dark, donor1	11502-119F8	28.95	2.39
Melanocyte - dark, donor2	11582-120F7	12.11	2.42
Melanocyte - dark, donor3	11663-122F7	41.00	7.75
Melanocyte - light, donor1	11274-116H5	63.70	5.17
Melanocyte - light, donor2	11351-117H1	55.96	2.73
Melanocyte - light, donor3	11423-118G1	43.36	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	45.09	6.56
Melanocyte, donor2 (MC+2)	12739-135I3	81.49	6.72
Melanocyte, donor3 (MC+3)	12837-137B2	65.36	4.02
Meningeal Cells, donor1	11493-119E8	40.07	8.06
Meningeal Cells, donor2	11573-120E7	36.09	7.48
Meningeal Cells, donor3	11654-122E7	33.42	5.38
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	30.23	7.70
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	12.98	2.31
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	52.57	5.26
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	48.40	5.23
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	41.62	3.59
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	14.19	3.81
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	21.11	2.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	50.54	8.79
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	50.41	8.77
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	52.99	9.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	15.51	3.74
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	34.20	9.66
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	18.16	2.63
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	10.98	2.67
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	11.68	7.01
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	45.47	8.33
Mesenchymal stem cells - adipose, donor0	11217-116B2	31.90	4.61
Mesenchymal stem cells - hepatic, donor0	11218-116B3	16.57	2.19
Mesenchymal stem cells - umbilical, donor0	11214-116A8	60.96	10.16
Mesothelial Cells, donor1	11247-116E5	12.73	1.86
Mesothelial Cells, donor2	12156-128G5	12.51	1.50
Mesothelial Cells, donor3	11402-118D7	12.65	1.66
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	93.17	5.40
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	50.24	5.42
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	23.56	3.83
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	76.06	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	37.19	3.10
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	21.99	2.70
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	69.48	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	39.04	4.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	30.26	6.05
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	38.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	38.81	3.66
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	24.15	4.36
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	42.76	8.55
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	36.28	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	20.14	3.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	48.69	2.63
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	33.32	3.40
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	23.02	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	215.66	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	32.19	2.09
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	21.80	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	33.95
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	25.09	2.76
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	17.59	1.43
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	17.14	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	18.19	2.30
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	15.14	1.68
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	21.61	1.83
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	22.53	1.50
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	16.67	2.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	12.48	0.88
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	19.26	2.03
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	21.54	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	11.14	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	17.35	1.76
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	16.35	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	12.01	2.40
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	17.21	1.60
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	12.34	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	12.01	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	16.31	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	7.88	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	17.66	2.21
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	12.81	1.28
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	9.92	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	11.83	2.09
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	33.15	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	9.91	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	13.13	2.19
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	13.14	1.42
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	10.10	1.40
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	11.64	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	18.65	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	9.95	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	12.94	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	36.09	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	11.08	1.85
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	19.92	2.28
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	17.96	3.04
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	12.96	0.78
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	25.74	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	33.67	3.81
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	12.01	1.60
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	22.45	2.10
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	18.22	2.26
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	19.43	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	20.12	3.32
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	29.20	4.55
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	15.34	1.70
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	21.14	2.70
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	22.16	2.61
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	24.99	4.70
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	17.59	1.44
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	32.97	6.59
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	26.50	3.57
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	90.41	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	44.56	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	78.86	7.23
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	67.32	6.31
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	72.35	6.92
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	37.25	5.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	56.70	3.76
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	40.22	6.92
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	54.18	3.17
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	53.78	2.21
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	77.68	3.66
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	85.56	4.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	35.81	5.34
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	96.60	11.59
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	81.81	5.05
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	36.68	2.53
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	5.45	6.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	6.36	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	10.53	1.62
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	13.59	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	39.97	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	26.10	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	25.85	2.80
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	15.68	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	59.41	4.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	54.68	3.34
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	60.66	4.37
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	44.68	7.98
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	29.24	2.04
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	25.73	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	21.76	3.35
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	42.77	3.25
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	41.07	1.89
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	25.02	4.41
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	23.83	3.47
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	20.57	1.35
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	20.85	2.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	23.19	1.96
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	14.94	1.09
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	12.73	3.71
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	19.21	1.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	14.11	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	22.44	1.63
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	15.70	2.29
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	16.88	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	22.53	1.84
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	16.71	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	17.59	1.72
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	14.70	2.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	24.13	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	19.94	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	24.04	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	26.32	3.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	16.68	1.35
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	20.24	1.98
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	16.72	3.71
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	15.13	2.27
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	23.46	1.96
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	27.45	3.92
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	15.83	3.17
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	25.58	2.65
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	9.97	2.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	19.84	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	23.74	4.59
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	27.83	1.81
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	17.24	1.99
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	12.20	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	15.85	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	23.92	2.52
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	28.75	2.12
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	10.28	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	14.74	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	0.00
Myoblast, donor1	11241-116D8	23.35	2.61
Myoblast, donor2	11322-117D8	28.96	2.49
Myoblast, donor3	11398-118D3	24.89	3.03
NK T cell leukemia cell line:KHYG-1	10777-110G3	61.15	7.59
Natural Killer Cells, donor1	11230-116C6	43.97	4.31
Natural Killer Cells, donor2	11311-117C6	59.11	3.32
Natural Killer Cells, donor3	11387-118C1	32.39	2.02
Neural stem cells, donor1	11275-116H6	22.87	3.27
Neural stem cells, donor2	11352-117H2	5.78	3.85
Neurons, donor1	11494-119E9	18.21	0.00
Neurons, donor2	11574-120E8	14.09	3.30
Neurons, donor3	11655-122E8	18.09	2.47
Neutrophils, donor1	11233-116C9	16.70	0.93
Neutrophils, donor2	11314-117C9	14.49	0.00
Neutrophils, donor3	11390-118C4	15.88	2.44
Nucleus Pulposus Cell, donor1	11252-116F1	11.75	1.78
Nucleus Pulposus Cell, donor2	11409-118E5	18.56	2.93
Nucleus Pulposus Cell, donor3	11462-119B4	13.04	2.01
Olfactory epithelial cells, donor1	11933-125I7	17.48	1.38
Olfactory epithelial cells, donor2	11934-125I8	19.54	2.17
Olfactory epithelial cells, donor3	11935-125I9	14.87	1.25
Olfactory epithelial cells, donor4	11936-126A1	22.50	1.95
Oligodendrocyte - precursors, donor1	11496-119F2	30.69	4.21
Osteoblast - differentiated, donor1	11276-116H7	9.57	1.91
Osteoblast - differentiated, donor2	11353-117H3	13.72	0.00
Osteoblast - differentiated, donor3	11425-118G3	14.90	0.62
Osteoblast, donor1	11277-116H8	31.86	6.64
Osteoblast, donor2	11354-117H4	42.14	4.21
Osteoblast, donor3	11426-118G4	32.70	5.33
Pancreatic stromal cells, donor1	11249-116E7	17.35	2.27
Pericytes, donor1	11491-119E6	20.47	6.01
Pericytes, donor2	11571-120E5	17.43	4.98
Pericytes, donor3	11652-122E5	40.28	4.48
Perineurial Cells, donor1	11499-119F5	29.61	5.43
Perineurial Cells, donor2	11579-120F4	17.02	2.30
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	47.49	3.19
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	48.48	1.96
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	38.31	4.01
Placental Epithelial Cells, donor1	11278-116H9	41.14	5.50
Placental Epithelial Cells, donor2	11355-117H5	67.64	5.54
Placental Epithelial Cells, donor3	11427-118G5	55.95	6.68
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	19.30	2.85
Preadipocyte - breast, donor1	11467-119B9	15.01	1.31
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	26.24	3.00
Preadipocyte - breast, donor2	11328-117E5	20.04	2.48
Preadipocyte - omental, donor1	11468-119C1	16.41	2.24
Preadipocyte - omental, donor2	11329-117E6	21.82	3.93
Preadipocyte - omental, donor3	11403-118D8	20.05	2.72
Preadipocyte - perirenal, donor1	11469-119C2	18.70	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	29.48	4.91
Preadipocyte - subcutaneous, donor2	11356-117H6	57.73	7.44
Preadipocyte - subcutaneous, donor3	11428-118G6	37.29	4.09
Preadipocyte - visceral, donor1	11280-116I2	37.91	5.78
Preadipocyte - visceral, donor2	11357-117H7	42.34	4.60
Preadipocyte - visceral, donor3	11429-118G7	32.29	3.76
Prostate Epithelial Cells (polarized), donor1	11253-116F2	31.53	3.32
Prostate Epithelial Cells, donor2	11331-117E8	55.52	6.50
Prostate Epithelial Cells, donor3	11404-118D9	102.76	6.55
Prostate Stromal Cells, donor1	11254-116F3	41.80	4.10
Prostate Stromal Cells, donor2	11332-117E9	53.97	6.45
Prostate Stromal Cells, donor3	11405-118E1	15.33	2.50
Renal Cortical Epithelial Cells, donor1	11516-119H4	40.88	5.84
Renal Cortical Epithelial Cells, donor2	11596-120H3	21.28	5.75
Renal Epithelial Cells, donor1	11517-119H5	70.00	14.20
Renal Epithelial Cells, donor2	11597-120H4	56.91	9.96
Renal Epithelial Cells, donor3	11678-122H4	26.57	6.03
Renal Glomerular Endothelial Cells, donor1	11514-119H2	36.77	4.77
Renal Glomerular Endothelial Cells, donor2	11594-120H1	35.71	5.39
Renal Glomerular Endothelial Cells, donor3	11675-122H1	56.17	8.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	49.91	9.32
Renal Mesangial Cells, donor1	11518-119H6	30.59	6.82
Renal Mesangial Cells, donor2	11598-120H5	41.38	3.13
Renal Mesangial Cells, donor3	11679-122H5	25.80	6.66
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	52.88	6.98
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	29.10	5.48
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	47.83	8.10
Retinal Pigment Epithelial Cells, donor0	11215-116A9	29.56	3.89
Retinal Pigment Epithelial Cells, donor1	11528-119I7	30.98	6.82
Retinal Pigment Epithelial Cells, donor2	11608-120I6	48.37	10.29
Retinal Pigment Epithelial Cells, donor3	11689-122I6	15.05	3.26
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	33.14	2.14
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	18.76	2.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	13.21	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	22.04	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	29.52	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	28.70	2.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	31.12	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	20.47	1.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	33.80	2.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	31.67	2.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	32.04	3.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	25.11	1.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	24.37	2.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	26.40	1.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	25.54	2.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	34.52	2.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	29.82	1.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	31.77	2.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	28.00	2.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	30.66	2.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	25.11	2.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	25.21	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	26.48	2.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	28.59	2.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	30.93	2.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	28.08	3.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	26.61	3.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	26.19	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	25.95	2.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	31.55	3.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	29.93	3.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	28.20	3.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	20.79	3.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	29.87	4.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	28.40	1.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	32.70	3.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	26.80	3.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	25.96	2.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	33.74	3.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	24.30	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	23.52	2.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	29.30	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	22.39	2.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	23.51	3.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	28.81	4.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	32.85	3.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	26.56	4.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	28.30	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	24.48	3.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	29.25	3.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	37.70	3.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	37.11	6.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	29.54	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	49.08	3.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	40.14	3.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	34.01	3.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	32.02	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	26.44	1.80
Schwann Cells, donor1	11498-119F4	61.31	15.99
Schwann Cells, donor2	11578-120F3	54.44	3.40
Schwann Cells, donor3	11659-122F3	46.01	5.48
Sebocyte, donor1	11220-116B5	52.04	4.38
Sebocyte, donor2	11301-117B5	35.85	4.60
Sebocyte, donor3	11378-118B1	43.49	4.12
Sertoli Cells, donor1	11255-116F4	34.79	0.00
Sertoli Cells, donor2	11333-117F1	16.95	2.82
Skeletal Muscle Cells, donor1	11281-116I3	26.48	4.31
Skeletal Muscle Cells, donor2	11358-117H8	12.29	3.61
Skeletal Muscle Cells, donor3	11430-118G8	64.37	8.36
Skeletal Muscle Cells, donor4	11451-119A2	29.38	6.28
Skeletal Muscle Cells, donor5	11455-119A6	28.39	4.46
Skeletal Muscle Cells, donor6	11459-119B1	38.32	8.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	18.65	3.28
Skeletal Muscle Satellite Cells, donor2	11321-117D7	22.40	3.28
Skeletal Muscle Satellite Cells, donor3	11397-118D2	39.39	5.65
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	22.66	2.95
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	51.39	5.07
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	11.15	2.48
Skin - palm, donor1	10286-104F7	104.76	8.06
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	71.36	11.82
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	145.58	30.26
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	83.22	9.35
Small Airway Epithelial Cells, donor1	11256-116F5	70.48	6.81
Small Airway Epithelial Cells, donor2	11334-117F2	92.13	8.44
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	145.90	21.14
Small Airway Epithelial Cells, donor3	11406-118E2	128.17	7.79
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	10.80	1.54
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	45.80	9.34
Smooth Muscle Cells - Aortic, donor0	11210-116A4	36.45	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	26.30	3.76
Smooth Muscle Cells - Aortic, donor2	11360-117I1	29.14	5.12
Smooth Muscle Cells - Aortic, donor3	11432-118H1	37.08	4.64
Smooth Muscle Cells - Bladder, donor1	11519-119H7	16.01	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	25.55	4.26
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	23.94	4.65
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	16.64	2.05
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	13.35	2.28
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	24.81	3.54
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	15.66	1.71
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	34.49	6.18
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	8.52	1.52
Smooth Muscle Cells - Carotid, donor1	11285-116I7	23.99	3.03
Smooth Muscle Cells - Carotid, donor2	11362-117I3	42.84	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	34.81	4.77
Smooth Muscle Cells - Colonic, donor1	11239-116D6	19.32	1.33
Smooth Muscle Cells - Colonic, donor2	11320-117D6	15.50	2.58
Smooth Muscle Cells - Colonic, donor3	11396-118D1	24.35	3.25
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	29.08	5.10
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	25.87	4.31
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	22.71	5.38
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	48.48	5.46
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	14.92	2.43
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	27.17	4.03
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	25.03	2.73
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	22.94	6.64
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	42.65	7.95
Smooth Muscle Cells - Prostate, donor1	11257-116F6	34.49	3.20
Smooth Muscle Cells - Prostate, donor2	11335-117F3	24.54	3.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	6.34	2.03
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	30.31	3.32
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	17.25	2.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	37.47	5.17
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	74.41	9.77
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	35.34	8.08
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	22.88	2.19
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	12.68	2.06
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	51.23	7.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	14.95	3.74
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	21.30	3.31
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	38.75	5.35
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	27.45	4.51
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	23.48	4.05
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	21.53	4.27
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	26.19	5.71
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	18.84	3.43
Smooth Muscle Cells - Uterine, donor1	11258-116F7	17.68	1.99
Smooth Muscle Cells - Uterine, donor3	11466-119B8	38.33	6.44
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	30.71	2.33
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	15.07	1.59
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	13.76	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	16.89	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	14.76	2.27
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	51.60	4.33
Smooth muscle cells - airway, control, donor1	11966-126D4	19.81	1.52
Smooth muscle cells - airway, control, donor2	11967-126D5	19.17	1.60
Smooth muscle cells - airway, control, donor3	11968-126D6	21.32	1.67
Smooth muscle cells - airway, control, donor4	11969-126D7	27.50	1.83
Synoviocyte, donor1	11291-117A4	29.62	2.02
Synoviocyte, donor2	11368-117I9	13.24	0.00
Synoviocyte, donor3	11440-118H9	10.95	1.12
Trabecular Meshwork Cells, donor1	11532-120A2	56.46	9.65
Trabecular Meshwork Cells, donor2	11612-122A1	69.37	5.95
Trabecular Meshwork Cells, donor3	11693-123A1	55.80	6.48
Tracheal Epithelial Cells, donor1	11292-117A5	47.60	4.95
Tracheal Epithelial Cells, donor2	11369-118A1	57.21	3.48
Tracheal Epithelial Cells, donor3	11441-118I1	67.00	6.30
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	26.57	3.20
Urethra, donor2	10319-105A4	79.13	3.60
Urothelial Cells, donor1	11520-119H8	44.90	6.91
Urothelial Cells, donor2	11600-120H7	56.48	2.40
Urothelial Cells, donor3	11681-122H7	62.57	8.25
Urothelial cells, donor0	11216-116B1	45.47	8.25
Whole blood (ribopure), donor090309, donation1	12179-129A1	28.47	6.23
Whole blood (ribopure), donor090309, donation2	12180-129A2	40.03	4.29
Whole blood (ribopure), donor090309, donation3	12181-129A3	24.64	2.74
Whole blood (ribopure), donor090325, donation1	12176-128I7	34.78	4.82
Whole blood (ribopure), donor090325, donation2	12177-128I8	27.31	5.81
Whole blood (ribopure), donor090612, donation1	12182-129A4	26.03	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	31.20	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	21.91	0.91
Wilms' tumor cell line:G-401	10809-111A8	47.86	5.92
Wilms' tumor cell line:HFWT	10597-108E3	54.56	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	56.70	7.54
achilles tendon, donor2	10292-104G4	12.40	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	36.71	7.90
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	72.44	13.93
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	45.94	13.89
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	72.65	23.40
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	63.24	6.46
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	66.41	13.75
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	65.33	11.98
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	59.05	12.34
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	78.00	14.70
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	74.16	9.71
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	24.47	5.70
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	11.70	23.40
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	75.99	10.69
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	74.56	13.72
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	101.12	16.95
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	52.05	10.22
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	64.16	3.29
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	87.79	12.89
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	85.77	7.25
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	80.68	9.10
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	99.65	11.79
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	63.93	6.46
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	60.04	10.01
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	92.91	13.01
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	67.42	9.79
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	41.00	14.39
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	74.98	16.87
adenocarcinoma cell line:IM95m	10796-110I4	129.76	10.13
adipose tissue, adult, pool1	10010-101C1	14.43	1.09
adipose, donor1	10184-103D4	31.08	5.28
adipose, donor2	10185-103D5	60.02	19.06
adipose, donor3	10186-103D6	50.10	12.25
adipose, donor4	10187-103D7	45.94	6.07
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	79.23	27.62
adrenal gland, adult, pool1	10081-102A9	21.83	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	45.62	9.87
alveolar cell carcinoma cell line:SW 1573	10708-109H6	40.02	2.50
amniotic membrane cells, donor1	12235-129G3	20.63	4.17
amniotic membrane cells, donor2	12236-129G4	29.41	4.06
amniotic membrane cells, donor3	12237-129G5	15.61	2.65
amygdala - adult, donor10196	10167-103B5	5.93	0.00
amygdala, adult, donor10252	10151-102I7	14.19	1.01
amygdala, newborn, donor10223	10360-105E9	12.59	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	15.79	3.69
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	52.95	7.72
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	61.80	9.69
aorta, adult, pool1	10052-101G7	11.77	0.98
appendix, adult	10189-103D9	25.62	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	148.92	10.32
artery, adult	10190-103E1	9.51	0.00
astrocytoma cell line:TM-31	10425-106D2	45.78	4.35
b cell line:RPMI1788	10427-106D4	27.81	12.49
basal cell carcinoma cell line:TE 354.T	10702-109G9	26.91	2.77
bile duct carcinoma cell line:HuCCT1	10432-106D9	45.15	5.06
bile duct carcinoma cell line:TFK-1	10496-107C1	58.42	1.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	118.00	13.98
bladder, adult, pool1	10011-101C2	18.58	1.41
blood, adult, pool1	10053-101G8	46.51	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	41.96	3.43
bone marrow, adult	10192-103E3	25.64	0.67
brain, adult, donor1	10084-102B3	10.25	1.03
brain, adult, pool1	10012-101C3	7.13	2.00
brain, fetal, pool1	10085-102B4	16.03	2.67
breast carcinoma cell line:MCF7	10482-107A5	85.23	3.30
breast carcinoma cell line:MDA-MB-453	10419-106C5	40.57	3.62
breast, adult, donor1	10080-102A8	44.19	1.89
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	78.64	9.15
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	92.46	17.01
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	24.63	8.98
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	44.06	3.87
carcinoid cell line:NCI-H1770	10703-109H1	58.30	6.11
carcinoid cell line:NCI-H727	10735-110B6	29.97	5.80
carcinoid cell line:SK-PN-DW	10719-109I8	73.52	7.29
carcinosarcoma cell line:JHUCS-1	10642-109A3	34.60	3.99
caudate nucleus - adult, donor10196	10177-103C6	11.51	0.00
caudate nucleus, adult, donor10252	10164-103B2	8.37	1.84
caudate nucleus, adult, donor10258	10379-105H1	7.64	1.53
caudate nucleus, newborn, donor10223	10354-105E3	11.72	2.20
cerebellum - adult, donor10196	10173-103C2	14.57	0.00
cerebellum, adult, donor10252	10166-103B4	10.03	1.28
cerebellum, adult, pool1	10083-102B2	3.45	2.07
cerebellum, newborn, donor10223	10357-105E6	31.55	4.15
cerebral meninges, adult	10188-103D8	4.54	1.01
cerebrospinal fluid, donor2	10294-104G6	11.69	2.19
cervical cancer cell line:D98-AH2	10552-107I3	42.99	2.44
cervical cancer cell line:ME-180	10553-107I4	137.21	5.97
cervix, adult, pool1	10013-101C4	38.11	4.30
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	18.39	1.95
chondrosarcoma cell line:SW 1353	10700-109G7	18.29	1.31
choriocarcinoma cell line:BeWo	10423-106C9	56.17	8.58
choriocarcinoma cell line:SCH	10785-110H2	55.69	6.28
choriocarcinoma cell line:T3M-3	10618-108G6	48.62	7.59
chorionic membrane cells, donor1	12238-129G6	30.77	5.13
chorionic membrane cells, donor2	12239-129G7	46.14	6.16
chorionic membrane cells, donor3	12240-129G8	40.11	4.95
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	62.61	15.15
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	175.58	23.24
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	58.71	9.08
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	43.14	10.79
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	52.73	11.85
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	48.26	11.40
chronic myelogenous leukemia cell line:K562	10454-106G4	78.33	7.36
chronic myelogenous leukemia cell line:KU812	10409-106B4	115.72	9.38
clear cell carcinoma cell line:JHOC-5	10638-108I8	40.92	10.51
clear cell carcinoma cell line:TEN	10636-108I6	56.22	6.25
colon carcinoma cell line:CACO-2	10513-107D9	58.94	6.04
colon carcinoma cell line:COLO-320	10420-106C6	58.53	10.64
colon, adult, donor1	10082-102B1	72.59	4.76
colon, adult, pool1	10014-101C5	31.73	2.94
colon, fetal, donor1	10070-101I7	53.77	4.94
common myeloid progenitor CMP, donor1	12130-128D6	165.01	4.58
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	31.45	3.40
cord blood derived cell line:COBL-a 24h infection	10453-106G3	58.26	6.34
cord blood derived cell line:COBL-a untreated	10449-106F8	55.42	6.06
corpus callosum, adult, pool1	10042-101F6	21.23	5.86
cruciate ligament, donor2	10295-104G7	34.85	2.43
diaphragm, fetal, donor1	10069-101I6	17.66	2.41
diencephalon, adult	10193-103E4	10.32	2.64
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	42.71	8.04
ductal cell carcinoma cell line:KLM-1	10438-106E6	89.75	8.21
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	56.57	5.30
ductus deferens, adult	10196-103E7	11.46	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	37.45	7.20
duodenum, fetal, donor1, tech_rep2	10071-101I8	22.81	5.15
dura mater, adult, donor1	10041-101F5	33.94	2.81
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	110.15	13.77
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	77.24	10.60
embryonic pancreas cell line:1B2C6	10604-108F1	32.68	9.87
embryonic pancreas cell line:1C3D3	10605-108F2	23.91	2.72
embryonic pancreas cell line:1C3IKEI	10606-108F3	44.15	4.63
embryonic pancreas cell line:2C6	10603-108E9	43.34	5.25
endometrial carcinoma cell line:OMC-2	10497-107C2	37.54	2.68
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	83.55	11.60
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	33.29	3.38
epidermoid carcinoma cell line:A431	10426-106D3	87.59	5.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	63.79	8.58
epididymis, adult	10197-103E8	14.02	2.30
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	34.95	3.19
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	35.00	3.15
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	84.92	2.49
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	90.84	4.33
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	79.77	4.15
esophagus, adult, pool1	10015-101C6	81.97	4.25
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	50.72	3.76
eye - muscle inferior rectus, donor1	10272-104E2	12.07	4.83
eye - muscle lateral, donor2	10298-104H1	6.31	2.10
eye - muscle medial, donor2	10299-104H2	13.39	0.00
eye - muscle superior, donor2	10297-104G9	20.64	3.44
eye - vitreous humor, donor1	10268-104D7	17.49	4.37
eye, fetal, donor1	10054-101G9	15.76	4.07
fibrosarcoma cell line:HT-1080	10758-110E2	18.59	2.69
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	63.63	8.78
frontal lobe, adult, pool1	10040-101F4	6.00	1.88
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	84.97	3.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	17.83	3.66
gall bladder, adult	10198-103E9	29.21	0.97
gamma delta positive T cells, donor1	11937-126A2	32.75	7.52
gamma delta positive T cells, donor2	11938-126A3	39.22	8.59
gastric adenocarcinoma cell line:MKN1	10614-108G2	51.75	2.96
gastric adenocarcinoma cell line:MKN45	10612-108F9	37.72	1.35
gastric cancer cell line:AZ521	10549-107H9	76.08	9.18
gastric cancer cell line:GSS	10560-108A2	61.32	25.63
gastrointestinal carcinoma cell line:ECC12	10615-108G3	25.82	3.20
giant cell carcinoma cell line:LU65	10487-107B1	26.28	1.84
giant cell carcinoma cell line:Lu99B	10433-106E1	4.34	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	89.79	6.24
glioblastoma cell line:A172, tech_rep1	10444-106F3	30.61	4.33
glioblastoma cell line:A172, tech_rep2	10444-106F3	35.81	5.20
glioblastoma cell line:T98G	10485-107A8	57.73	7.62
glioma cell line:GI-1	10413-106B8	40.71	4.10
globus pallidus - adult, donor10196	10175-103C4	17.49	1.46
globus pallidus, adult, donor10252	10161-103A8	26.85	2.20
globus pallidus, adult, donor10258	10367-105F7	21.91	1.37
globus pallidus, newborn, donor10223	10364-105F4	23.98	2.13
granulocyte macrophage progenitor, donor1	12131-128D7	171.30	17.13
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	21.86
granulocyte macrophage progenitor, donor3	12139-128E6	26.13	0.00
granulosa cell tumor cell line:KGN	10624-108H3	28.16	2.56
hIPS +CCl2, biol_rep1	14383-156B9	63.82	6.89
hIPS +CCl2, biol_rep2	14384-156C1	37.04	4.57
hIPS +CCl2, biol_rep3	14385-156C2	68.27	8.37
hIPS, biol_rep1	14380-156B6	54.62	11.50
hIPS, biol_rep2	14381-156B7	71.33	4.80
hIPS, biol_rep3	14382-156B8	13.24	2.21
hairy cell leukemia cell line:Mo	10712-109I1	59.19	10.34
heart - mitral valve, adult	10205-103F7	9.27	1.49
heart - pulmonic valve, adult	10206-103F8	9.41	0.78
heart - tricuspid valve, adult	10207-103F9	10.82	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	35.71	2.86
heart, adult, diseased, donor1	10051-101G6	3.83	1.28
heart, adult, pool1	10016-101C7	8.97	0.92
heart, fetal, pool1	10046-101G1	14.17	2.36
hepatic mesenchymal tumor cell line:LI90	10778-110G4	26.22	4.63
hepatoblastoma cell line:HuH-6	10633-108I3	60.65	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	64.20	2.10
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	56.68	2.67
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	65.79	3.94
hepatoma cell line:Li-7	10484-107A7	40.70	0.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	56.28	8.74
hippocampus - adult, donor10196	10169-103B7	11.36	0.00
hippocampus, adult, donor10252	10153-102I9	13.27	1.84
hippocampus, adult, donor10258	10374-105G5	4.98	1.99
hippocampus, newborn, donor10223	10363-105F3	10.57	2.11
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	59.81	8.54
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	60.28	5.89
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	64.74	7.62
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	74.43	18.04
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	58.10	17.82
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	55.42	18.60
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	62.48	15.77
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	50.63	22.62
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	65.48	12.10
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	38.60	7.10
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	46.61	9.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	36.36	6.73
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	50.54	5.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	57.48	6.88
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	43.64	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	75.41	15.27
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	64.10	15.70
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	59.47	15.99
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	37.49	14.69
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	38.20	11.37
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	47.93	15.98
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	44.74	10.12
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	30.48	9.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	52.01	8.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	70.57	7.94
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	76.74	9.13
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	73.09	6.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	60.56	11.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	76.33	14.25
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	77.17	15.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	57.40	13.96
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	52.47	15.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	44.38	14.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	38.35	7.67
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	46.19	11.36
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	51.75	10.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	62.07	8.94
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	69.52	5.79
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	65.37	8.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	67.24	19.87
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	13.01	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	49.97	13.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	66.77	22.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	52.84	24.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	45.20	17.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	32.22	7.16
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	45.37	13.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	44.72	9.70
immature langerhans cells, donor1	11904-125F5	13.56	1.45
immature langerhans cells, donor2	11905-125F6	57.03	4.75
insula, adult, pool1	10039-101F3	7.38	2.37
keratoacanthoma cell line:HKA-1	10791-110H8	263.69	9.43
kidney, adult, pool1	10017-101C8	13.12	2.10
kidney, fetal, pool1	10045-101F9	14.57	2.55
large cell lung carcinoma cell line:IA-LM	10509-107D5	22.30	3.55
large cell lung carcinoma cell line:NCI-H460	10839-111E2	36.22	2.90
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	63.67	6.61
left atrium, adult, donor1	10079-102A7	10.90	1.63
left ventricle, adult, donor1	10078-102A6	10.11	0.51
leiomyoblastoma cell line:G-402	10721-110A1	40.49	5.20
leiomyoma cell line:10964C	10569-108B2	12.93	2.16
leiomyoma cell line:15242A	10570-108B3	20.11	3.26
leiomyoma cell line:15425	10571-108B4	17.24	2.19
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	43.91	7.32
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	159.38	13.69
liposarcoma cell line:KMLS-1	10782-110G8	15.00	4.37
liposarcoma cell line:SW 872	10726-110A6	61.65	4.39
liver, adult, pool1	10018-101C9	12.48	1.46
liver, fetal, pool1	10086-102B5	24.46	0.94
locus coeruleus - adult, donor10196	10182-103D2	10.06	2.04
locus coeruleus, adult, donor10252	10165-103B3	17.72	2.77
locus coeruleus, adult, donor10258	10375-105G6	16.93	4.23
locus coeruleus, newborn, donor10223	10362-105F2	15.98	1.26
lung adenocarcinoma cell line:A549	10499-107C4	49.55	4.84
lung adenocarcinoma cell line:PC-14	10408-106B3	62.74	8.27
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	22.28	2.64
lung, adult, pool1	10019-101D1	30.59	3.78
lung, fetal, donor1	10068-101I5	14.56	3.42
lung, right lower lobe, adult, donor1	10075-102A3	54.07	4.12
lymph node, adult, donor1	10077-102A5	32.19	2.37
lymphangiectasia cell line:DS-1	10727-110A7	29.81	10.30
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	10.26	1.81
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	80.70	5.10
mature adipocyte, donor1	12231-129F8	9.32	1.78
mature adipocyte, donor2	12232-129F9	9.34	1.04
mature adipocyte, donor3	12233-129G1	10.19	0.95
mature adipocyte, donor4	12234-129G2	9.74	1.05
maxillary sinus tumor cell line:HSQ-89	10414-106B9	32.16	6.19
medial frontal gyrus - adult, donor10196	10170-103B8	4.51	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	11.59	1.66
medial frontal gyrus, adult, donor10258	10368-105F8	7.62	1.91
medial frontal gyrus, newborn, donor10223	10352-105E1	3.41	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	5.91	2.70
medial temporal gyrus, adult, donor10252	10156-103A3	15.49	2.33
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	5.78	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	6.46	1.44
medulla oblongata - adult, donor10196	10174-103C3	21.42	2.60
medulla oblongata, adult, donor10252	10155-103A2	20.43	3.10
medulla oblongata, adult, pool1	10038-101F2	14.77	3.84
medulla oblongata, newborn, donor10223	10361-105F1	28.47	3.12
medulloblastoma cell line:D283 Med	10838-111E1	53.36	7.31
medulloblastoma cell line:ONS-76	10759-110E3	85.71	8.56
melanoma cell line:COLO 679	10514-107E1	34.36	6.76
melanoma cell line:G-361	10465-106H6	78.72	12.22
meningioma cell line:HKBMM	10691-109F7	16.82	1.63
merkel cell carcinoma cell line:MKL-1	10843-111E6	22.03	3.52
merkel cell carcinoma cell line:MS-1	10844-111E7	29.03	4.93
mesenchymal precursor cell - adipose, donor1	11747-123G1	27.62	4.45
mesenchymal precursor cell - adipose, donor2	11748-123G2	15.09	1.82
mesenchymal precursor cell - adipose, donor3	11749-123G3	16.15	1.66
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	7.59	0.70
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	8.86	0.96
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	9.72	2.78
mesenchymal precursor cell - cardiac, donor1	11752-123G6	10.30	1.54
mesenchymal precursor cell - cardiac, donor2	11753-123G7	10.35	2.07
mesenchymal precursor cell - cardiac, donor3	11754-123G8	21.89	3.71
mesenchymal precursor cell - cardiac, donor4	11755-123G9	29.30	3.51
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	15.93	2.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	10.54	1.32
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	23.52	3.46
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	20.94	3.14
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	10.41	1.63
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	14.38	4.67
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	9.83	2.59
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	20.52	2.74
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	26.43	4.62
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	12.85	2.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	16.28	1.93
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	12.89	2.21
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	16.60	3.43
mesenchymal stem cell line:Hu5/E18	10568-108B1	42.94	7.16
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	12.79	3.65
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	14.84	2.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	14.13	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	16.33	2.16
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	17.42	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	17.26	1.69
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	13.36	1.96
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	18.07	3.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	18.46	1.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	17.62	2.01
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	17.31	2.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	19.80	2.93
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	20.81	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	20.06	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	18.04	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	21.88	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	12.99	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	18.91	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	19.19	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	14.72	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	17.49	2.33
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	18.89	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	8.94	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	13.05	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	10.97	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	16.47	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	16.90	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	30.09	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	11.41	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	19.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	12.38	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	14.65	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	12.03	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	15.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	10.27	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	15.83	2.75
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	14.84	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	7.85	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	13.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	18.54	2.01
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	23.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	25.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	21.24	1.82
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	40.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	26.36	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	19.25	1.19
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	16.22	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	14.26	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	19.34	4.64
mesothelioma cell line:ACC-MESO-1	10493-107B7	61.42	7.32
mesothelioma cell line:ACC-MESO-4	10494-107B8	60.93	6.26
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	50.24	2.47
mesothelioma cell line:Mero-25	10850-111F4	42.44	3.63
mesothelioma cell line:Mero-41	10851-111F5	24.20	1.22
mesothelioma cell line:Mero-48a	10852-111F6	13.06	1.11
mesothelioma cell line:Mero-82	10853-111F7	53.09	2.63
mesothelioma cell line:Mero-83	10854-111F8	21.11	1.70
mesothelioma cell line:Mero-84	10855-111F9	63.45	7.33
mesothelioma cell line:Mero-95	10856-111G1	30.02	3.93
mesothelioma cell line:NCI-H2052	10847-111F1	22.86	1.99
mesothelioma cell line:NCI-H226	10846-111E9	40.90	2.35
mesothelioma cell line:NCI-H2452	10848-111F2	23.74	2.90
mesothelioma cell line:NCI-H28	10845-111E8	27.48	3.05
mesothelioma cell line:No36	10857-111G2	39.80	2.61
mesothelioma cell line:ONE58	10858-111G3	27.37	1.63
migratory langerhans cells, donor1	11901-125F2	10.17	4.99
migratory langerhans cells, donor2	11902-125F3	22.10	5.74
migratory langerhans cells, donor3	11903-125F4	22.26	5.74
mixed mullerian tumor cell line:HTMMT	10689-109F5	18.61	1.31
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	42.39	3.18
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	52.29	2.30
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	26.45	5.71
myelodysplastic syndrome cell line:SKM-1	10772-110F7	156.52	10.90
myeloma cell line:PCM6	10474-106I6	115.44	7.51
myxofibrosarcoma cell line:MFH-ino	10600-108E6	38.55	6.09
myxofibrosarcoma cell line:NMFH-1	10684-109E9	38.44	4.90
nasal epithelial cells, donor1, tech_rep1	12226-129F3	100.28	8.91
nasal epithelial cells, donor1, tech_rep2	12226-129F3	98.18	7.13
nasal epithelial cells, donor2	12227-129F4	73.41	5.52
neuroblastoma cell line:CHP-134	10508-107D4	38.65	5.98
neuroblastoma cell line:NB-1	10539-107G8	50.33	5.43
neuroblastoma cell line:NBsusSR	10607-108F4	33.74	6.12
neuroblastoma cell line:NH-12	10555-107I6	32.98	10.25
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	34.40	1.90
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	72.06	5.23
neuroectodermal tumor cell line:TASK1	10774-110F9	40.05	3.62
neuroepithelioma cell line:SK-N-MC	10728-110A8	155.13	17.80
neurofibroma cell line:Hs 53.T	10729-110A9	32.47	2.93
neutrophil PMN, donor1	12133-128D9	148.75	0.00
neutrophil PMN, donor2	12137-128E4	26.56	26.56
neutrophil PMN, donor3	12141-128E8	18.94	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	102.15	23.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	32.82	4.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	25.65	3.21
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	23.65	3.15
nucleus accumbens, adult, pool1	10037-101F1	7.97	1.50
occipital cortex - adult, donor10196	10172-103C1	4.12	0.00
occipital cortex, adult, donor10252	10163-103B1	15.30	4.29
occipital cortex, newborn, donor10223	10355-105E4	9.46	0.73
occipital lobe, adult, donor1	10076-102A4	10.76	0.79
occipital lobe, fetal, donor1	10073-102A1	7.72	3.00
occipital pole, adult, pool1	10036-101E9	4.18	1.66
olfactory region, adult	10195-103E6	6.30	1.72
optic nerve, donor1	10277-104E7	38.02	12.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	111.86	6.95
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	40.53	8.11
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	65.02	3.05
oral squamous cell carcinoma cell line:SAS	10544-107H4	65.72	6.93
osteoclastoma cell line:Hs 706.T	10704-109H2	46.74	4.41
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	66.34	10.28
osteosarcoma cell line:HS-Os-1	10558-107I9	50.68	3.39
ovary, adult, pool1	10020-101D2	11.97	1.66
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	39.05	6.97
pancreas, adult, donor1	10049-101G4	24.46	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	53.11	2.80
papillary adenocarcinoma cell line:8505C	10437-106E5	26.40	3.07
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	26.99	6.62
paracentral gyrus, adult, pool1	10035-101E8	5.58	1.74
parietal cortex, adult, donor10258	10373-105G4	6.61	1.47
parietal lobe - adult, donor10196	10171-103B9	7.52	0.94
parietal lobe, adult, donor10252	10157-103A4	11.40	2.57
parietal lobe, adult, pool1	10034-101E7	7.14	2.03
parietal lobe, fetal, donor1	10072-101I9	5.82	0.97
parietal lobe, newborn, donor10223	10356-105E5	6.36	1.87
parotid gland, adult	10199-103F1	12.33	1.23
penis, adult	10200-103F2	21.48	3.22
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	20.82	3.35
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	56.82	5.97
pineal gland - adult, donor10196	10179-103C8	11.61	1.94
pineal gland, adult, donor10252	10160-103A7	10.66	6.51
pineal gland, adult, donor10258	10377-105G8	7.52	3.76
pituitary gland - adult, donor10196	10180-103C9	11.13	6.07
pituitary gland, adult, donor10252	10162-103A9	11.47	4.17
pituitary gland, adult, donor10258	10378-105G9	21.28	8.51
placenta, adult, pool1	10021-101D3	78.58	9.03
plasma cell leukemia cell line:ARH-77	10840-111E3	36.28	6.75
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	20.39	2.33
pons, adult, pool1	10033-101E6	10.07	2.50
postcentral gyrus, adult, pool1	10032-101E5	7.32	1.31
promyelocytes/myelocytes PMC, donor1	12132-128D8	89.93	20.91
promyelocytes/myelocytes PMC, donor2	12136-128E3	27.54	22.03
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	60.30	5.54
prostate cancer cell line:PC-3	10439-106E7	95.11	6.35
prostate, adult, pool1	10022-101D4	22.67	3.26
putamen, adult, donor10196	10176-103C5	7.32	0.94
putamen, adult, donor10252	10152-102I8	17.65	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	14.21	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	2.90	0.97
putamen, newborn, donor10223	10365-105F5	6.75	0.75
rectal cancer cell line:TT1TKB	10469-106I1	16.00	1.45
rectum, fetal, donor1	10067-101I4	23.65	6.95
renal cell carcinoma cell line:OS-RC-2	10411-106B6	25.44	4.88
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	20.30	2.49
retina, adult, pool1	10030-101E3	13.22	3.48
retinoblastoma cell line:Y79	10475-106I7	56.90	10.65
rhabdomyosarcoma cell line:KYM-1	10787-110H4	65.53	8.73
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	114.45	5.91
sacrococcigeal teratoma cell line:HTST	10695-109G2	18.19	1.52
salivary acinar cells, donor1	11771-123I7	43.05	2.75
salivary acinar cells, donor2	11772-123I8	50.26	3.58
salivary acinar cells, donor3	11773-123I9	155.58	2.65
salivary gland, adult, pool1	10093-102C3	14.30	1.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	26.47	2.45
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	33.38	3.17
seminal vesicle, adult	10201-103F3	15.34	2.65
serous adenocarcinoma cell line:JHOS-2	10639-108I9	17.73	2.92
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	13.84	2.26
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	39.14	4.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	127.20	11.69
signet ring carcinoma cell line:Kato III	10436-106E4	120.48	11.61
signet ring carcinoma cell line:NUGC-4	10483-107A6	64.00	4.00
skeletal muscle - soleus muscle, donor1	10282-104F3	1.42	2.13
skeletal muscle, adult, pool1	10023-101D5	7.32	1.56
skeletal muscle, fetal, donor1	10066-101I3	22.11	3.02
skin, adult, donor1	10074-102A2	115.35	13.57
skin, fetal, donor1	10065-101I2	39.77	3.79
small cell cervical cancer cell line:HCSC-1	10800-110I8	30.02	9.01
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	115.37	16.08
small cell lung carcinoma cell line:DMS 144	10841-111E4	31.80	8.48
small cell lung carcinoma cell line:LK-2	10541-107H1	69.39	5.77
small cell lung carcinoma cell line:NCI-H82	10842-111E5	51.63	16.25
small cell lung carcinoma cell line:WA-hT	10562-108A4	11.99	1.31
small intestine, adult, pool1	10024-101D6	22.81	2.51
small intestine, fetal, donor1	10064-101I1	24.08	4.42
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	14.36	5.13
smooth muscle, adult, pool1	10048-101G3	11.63	1.29
somatostatinoma cell line:QGP-1	10781-110G7	20.10	4.02
spinal cord - adult, donor10196	10181-103D1	22.71	2.06
spinal cord, adult, donor10252	10159-103A6	27.20	2.37
spinal cord, adult, donor10258	10369-105F9	20.75	0.69
spinal cord, fetal, donor1	10056-101H2	34.76	6.10
spinal cord, newborn, donor10223	10359-105E8	32.60	4.59
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	50.18	6.72
spleen, adult, pool1	10025-101D7	47.69	3.30
spleen, fetal, pool1	10044-101F8	35.91	4.53
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	24.64	4.45
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	97.22	5.51
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	56.96	9.09
squamous cell carcinoma cell line:T3M-5	10616-108G4	39.87	2.35
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	41.31	3.38
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	80.06	7.20
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	34.69	1.69
stomach, fetal, donor1	10062-101H8	52.33	12.82
submaxillary gland, adult	10202-103F4	11.39	2.28
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	21.39	3.74
substantia nigra, adult, donor10258	10371-105G2	10.35	1.03
substantia nigra, newborn, donor10223	10358-105E7	43.81	3.53
synovial sarcoma cell line:HS-SY-II	10441-106E9	43.33	4.81
temporal lobe, adult, pool1	10031-101E4	7.54	2.03
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	6.41	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	7.47	1.32
tenocyte, donor1	11763-123H8	29.32	3.49
tenocyte, donor2	11765-123I1	12.59	1.14
tenocyte, donor3	11768-123I4	23.35	2.59
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	45.89	5.95
teratocarcinoma cell line:NCR-G1	10798-110I6	69.06	10.48
teratocarcinoma cell line:PA-1	10807-111A6	33.48	6.51
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	73.12	3.17
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	58.24	1.89
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	19.19	0.98
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	40.71	6.84
testis, adult, pool1	10026-101D8	56.37	8.91
testis, adult, pool2	10096-102C6	70.82	13.08
thalamus - adult, donor10196	10168-103B6	14.35	6.62
thalamus, adult, donor10252	10154-103A1	23.44	1.88
thalamus, adult, donor10258, tech_rep1	10370-105G1	13.86	6.16
thalamus, adult, donor10258, tech_rep2	10370-105G1	18.28	3.46
thalamus, newborn, donor10223	10366-105F6	10.93	1.15
throat, adult	10209-103G2	40.70	3.99
throat, fetal, donor1	10061-101H7	23.16	3.96
thymic carcinoma cell line:Ty-82	10803-111A2	81.08	8.94
thymus, adult, pool1	10027-101D9	35.89	6.06
thymus, fetal, pool1	10043-101F7	40.00	7.79
thyroid carcinoma cell line:KHM-5M	10776-110G2	46.94	4.12
thyroid carcinoma cell line:TCO-1	10783-110G9	25.98	3.07
thyroid, adult, pool1	10028-101E1	29.39	4.11
thyroid, fetal, donor1	10060-101H6	26.10	5.27
tongue epidermis (fungiform papillae), donor1	10288-104F9	101.63	6.16
tongue, adult	10203-103F5	45.12	2.79
tongue, fetal, donor1	10059-101H5	37.83	4.34
tonsil, adult, pool1	10047-101G2	75.23	5.61
trachea, adult, pool1	10029-101E2	23.48	3.44
trachea, fetal, donor1	10058-101H4	19.23	2.69
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	34.36	4.96
transitional-cell carcinoma cell line:5637	10418-106C4	57.04	6.38
transitional-cell carcinoma cell line:JMSU1	10492-107B6	39.49	2.51
tridermal teratoma cell line:HGRT	10694-109G1	47.56	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	18.88	2.54
umbilical cord, fetal, donor1	10057-101H3	27.12	0.00
uterus, adult, pool1	10100-102D1	16.55	3.75
uterus, fetal, donor1	10055-101H1	30.20	5.63
vagina, adult	10204-103F6	24.56	0.65
vein, adult	10191-103E2	18.19	4.60
xeroderma pigentosum b cell line:XPL 17	10563-108A5	17.09	4.54